DMYD B — Diamyd Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.45bn
- SEK1.22bn
- SEK0.13m
Annual cashflow statement for Diamyd Medical AB, fiscal year end - August 31st, SEK millions except per share, conversion factor applied.
2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -85.9 | -118 | -121 | -147 | -183 |
| Depreciation | |||||
| Non-Cash Items | 0.362 | 3.24 | 5.37 | -5.26 | 2.04 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -24.7 | 17.3 | -0.399 | 11.7 | 5.01 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -109 | -93.2 | -111 | -129 | -170 |
| Capital Expenditures | -4.22 | -34.7 | -11.4 | -8.03 | -10 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 137 | -42.1 | 39.8 | -20 | 27.2 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 133 | -76.7 | 28.4 | -28 | 17.2 |
| Financing Cash Flow Items | -3.28 | -7.84 | -4.59 | -7.73 | -13.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 56.7 | 142 | 86.5 | 142 | 316 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 81 | -19.6 | 7.77 | -14.8 | 164 |